Aside from the basic science work described above, physician-scientist members of our team published the following clinical studies in 2018:
- Medical student Cecilia Dalle Ore published a study in which she found that the presence of treatment effect in specimens generated from surgery for recurrent glioblastoma did not aversely impact patient prognosis.
- HHMI fellow Jonathan Rick published a study in which he found that 25% of the pituitary tumors in acromegalic patients stain for prolactin in addition to growth hormone and that these dual staining hormones had more aggressive clinical presentations and postoperative outcomes than acromegalics whose tumors just stained for growth hormone.
- HHMI fellow Ankush Chandra published a study in which he defined the worse outcomes that glioblastoma patients with limited insurance or no primary care physician are confronted with.
- UCSF medical student Fara Dayani and UCSF neurosurgery resident Jake Young published a study in which they found that patients with bilateral "butterfly" glioblastomas experience a prognostic benefit with surgical resection with a minimum extent of resection of 86% needed to observe survival benefits.